Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Trader Michael Capolino, right, works on the floor of the New York Stock Exchange Monday, May 19, 2014. (Richard Drew/AP)
Trader Michael Capolino, right, works on the floor of the New York Stock Exchange Monday, May 19, 2014. (Richard Drew/AP)

At midday: Global shares trade near break-even as Pfizer deal weighs Add to ...

Global equity markets traded near break-even on Monday as Pfizer’s failed bid for AstraZeneca weighed on European shares but helped lift Wall Street, while declining yields on government debt also helped buoy U.S. stocks.

AstraZeneca <AZN.L> rejected a sweetened and “final” offer from Pfizer <PFE.N>, sending the British drugmaker’s shares down more than 10 per cent in London and making it the biggest weight on a pan-European index of leading regional companies.

More Related to this Story

Pfizer’s shares rebounded on the failed bid, making it the second-largest contributor to a rise in the S&P 500 index after Apple. Pfizer rose 1.27 per cent to $29.49 a share, while AstraZeneca fell 10.8 per cent to 43 pounds in London.

Treasuries, meanwhile, rallied. Yields on the benchmark 10-year U.S. Treasury note fell to 2.50 per cent, lows last seen in October.

Analysts had expected interest rates to rise, but with rates touching seven-month lows, the bond rally has helped U.S. stocks from falling further.

“It’s easy to see why the market is very, very quiet, except the big story is the bond market, that is the one thing that stands out like a sore thumb,” said Stephen Massocca, managing director at Wedbush Equity Management LLC in San Francisco.

Tim Ghriskey, chief investment officer of Solaris Group in Bedford Hills, New York, said equity investors still see an improving U.S. economy yet the bond market sees otherwise.

“You really have this dichotomy going in and nobody is winning and we are stuck in neutral a bit because of that,” Ghriskey said.

MSCI’s all-world equity index <.MIWD00000PUS>, which tracks shares in 45 nations, rose 0.5 points or 0.12 per cent, to 415.3.

The pan-European FTSEurofirst 300 index <.FTEU3>, which last week hit a 6-year high of 1,372.81 points, was down 0.17 per cent at 1,359.22 points.

U.S. Treasuries prices edged higher on sentiment that bond yields could hit multi-month lows again, leading investors to mainly seek longer-dated bonds to avoid price losses.

“When we get this dropping of yield, the folks that have not participated have really lagged from a performance perspective,” said Justin Hoogendoorn, fixed income strategist at BMO Capital Markets in Chicago. “You don’t want to be caught off-side.”

Benchmark 10-year U.S. Treasury notes were last up 2/32 in price to yield 2.5089 per cent.

The dollar fell to its lowest in more than three months against the yen, pressured by the drop in U.S. Treasury yields that may be due to persistent uncertainty about U.S. economic growth prospects.

The dollar fell as low as 101.11 yen, the weakest since early February. It was last at 101.27, down 0.22 per cent.

The euro gained 0.18 per cent on Monday to $1.3717.

Brent crude rose above $110 a barrel on renewed concerns over Libya’s oil output following some of the worst violence in Tripoli since the 2011 war against Muammar Gaddafi.

Brent later retreated. Brent fell 6 cents to $109.69 a barrel. U.S. crude rose 67 cents to $102.70.

Follow us on Twitter: @GlobeInvestor

  • PFE-N
  • AZN-N
  • DJIA-I
  • SPX-I
  • COMP-I
  • GC-FT
  • CL-FT
Live Discussion of PFE on StockTwits
More Discussion on PFE-N
Live Discussion of AZN on StockTwits
More Discussion on AZN-N
Live Discussion of DJIA on StockTwits
More Discussion on DJIA-I
Live Discussion of SPX on StockTwits
More Discussion on SPX-I
Live Discussion of COMP on StockTwits
More Discussion on COMP-I
Live Discussion of GC on StockTwits
More Discussion on GC-FT
Live Discussion of CL on StockTwits
More Discussion on CL-FT

More Related to this Story


In the know

Most popular video »


More from The Globe and Mail

Most Popular Stories